-The Hindu More significant than the issue of whether women should be allowed entry into the Sabarimala temple is the question of whether secular judges ought to be the ones making that call. The more the state takes over the task of social reform, the less likely is the desired change to emerge from within the society Last week, the Supreme Court declared that it would hear a public interest litigation (PIL)...
More »SEARCH RESULT
Total Matching Records found : 536
HC scan on odd-even
-The Telegraph New Delhi: Delhi High Court today dubbed the Kejriwal regime’s vehicle-rationing report as “vague” and asked it to submit on Friday a revised one having specific data on changes in pollution levels from January 1-7. Focussing on “insufficient” public transport and “inconvenience” caused to commuters, the court asked the government to consider winding up the odd-even scheme on Friday instead of carrying on for a fortnight. The 8am to 8pm rationing...
More »Women’s right to decent loos upheld by HC -Rosy Sequeira
-The Times of India MUMBAI: Women have the right to have safe and decent toilets at all convenient places, observed the Bombay high court on Wednesday upholding the "right to pee" for women who are outdoors. "Women have the right to safe and clean toilets which in a way impacts their right to live with human dignity,'' said a bench of Justice Abhay Oka and Justice Revati Mohite-Dere in their judgment. "One...
More »Why the FIR doesn’t tell you the whole story -Rukmini S
-The Hindu A complex picture emerges from the analysis of a year of Mumbai sessions court rulings on sexual assault: false cases foisted by parents, wide variation in the sentences, societal prejudices and vulnerabilities at play, and a tendency for investigating high-profile cases with greater rigour Over half of all sexual assault cases decided by Mumbai’s sessions courts in 2015 involved either parents filing cases against young couples who had eloped, or...
More »Affordable Drugs Need a Compensatory Patent Commons -Shamnad Basheer
-TheWire.in In a case that will once again prove that India is not out to arbitrarily purge all pharmaceutical patents, the Delhi high court has ruled in favour of Roche, a Swiss multinational. Many years ago, Roche dragged Cipla to court arguing that Cipla’s product infringed its patented anticancer drug, Erlotinib (brand name ‘Tarceva’). After a protracted legal battle fought over seven hard years, Roche finally won. But so did Cipla. Indeed,...
More »
